Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Bonardi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Hybridoma|April 1, 1994
Production and characterization of monoclonal antibodies against the ribosome inactivating proteins dianthin32 and momochinG Porro, M A Bonardi, E Giovanetti, et al.
Pharmacological Research|September 1, 1992
Activation of rat T cells in vitro and in vivo with a bispecific (anti-TCR x anti-CD2) F(ab')2 derivativeM A Bonardi, A Tutt, G Gromo, et al.
Cancer Research|July 1, 1993
Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killingM A Bonardi, R R French, P Amlot, et al.
Biochemical and Biophysical Research Communications|January 5, 1995
Cochaperonins are histone-binding proteinsM A Bonardi, E Giovanetti, G Legname, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 1998
Diaminic carbonates, a new class of anti-inflammatory compounds: their biological characterization and mode of actionG Porro, G Bertolini, M A Bonardi, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Initial experience in treating human lymphoma with a combination of bispecific antibody and saporinM A Bonardi, A Bell, R R French, et al.
Molecular and Cellular Probes|March 1, 1989
Preparation and characterization of anti-human chromogranin A and chromogranin B (secretogranin I) monoclonal antibodiesM Pelagi, C Bisiani, A Gini, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Hybridoma|April 1, 1994
Production and characterization of monoclonal antibodies against the ribosome inactivating proteins dianthin32 and momochinG Porro, M A Bonardi, E Giovanetti, et al.
Pharmacological Research|September 1, 1992
Activation of rat T cells in vitro and in vivo with a bispecific (anti-TCR x anti-CD2) F(ab')2 derivativeM A Bonardi, A Tutt, G Gromo, et al.
Cancer Research|July 1, 1993
Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killingM A Bonardi, R R French, P Amlot, et al.
Biochemical and Biophysical Research Communications|January 5, 1995
Cochaperonins are histone-binding proteinsM A Bonardi, E Giovanetti, G Legname, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 1998
Diaminic carbonates, a new class of anti-inflammatory compounds: their biological characterization and mode of actionG Porro, G Bertolini, M A Bonardi, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Initial experience in treating human lymphoma with a combination of bispecific antibody and saporinM A Bonardi, A Bell, R R French, et al.
Molecular and Cellular Probes|March 1, 1989
Preparation and characterization of anti-human chromogranin A and chromogranin B (secretogranin I) monoclonal antibodiesM Pelagi, C Bisiani, A Gini, et al.
Pageof 1